These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 762813)

  • 61. Antihypertensive effect of prazosin in combination with methyldopa, clonidine, or propranolol.
    Kuokkanen K; Mattila MJ
    Ann Clin Res; 1979 Feb; 11(1):18-24. PubMed ID: 453775
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Comparison between propranolol and methyldopa in the treatment of hypertension (a double-blind trial)].
    Brahm M
    Ugeskr Laeger; 1973 May; 135(20):974-6. PubMed ID: 4585571
    [No Abstract]   [Full Text] [Related]  

  • 63. Methyldopa supplement for resistant essential hypertension: a prospective randomized placebo control crossover study.
    Sermswan A; Archawarak N
    J Med Assoc Thai; 2003 Dec; 86(12):1156-61. PubMed ID: 14971524
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rapid control of severe hypertension with minoxidil.
    Alpert MA; Bauer JH
    Arch Intern Med; 1982 Nov; 142(12):2099-104. PubMed ID: 6753777
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Standardized stress and hypertension: comparison of effect of propranolol and methyldopa.
    Dunn FG; Melville DI; Jones JV; Lorimer AR; Lawrie TD
    Br J Clin Pharmacol; 1978 Mar; 5(3):223-6. PubMed ID: 656266
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Propranolol in pregnancy three year prospective study.
    Livingstone I; Craswell PW; Bevan EB; Smith MT; Eadie MJ
    Clin Exp Hypertens B; 1983; 2(2):341-50. PubMed ID: 6872291
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Interaction of dopamine, methyldopa and reserpine in the sympatho-adrenal system in essential hypertension.
    Abe K; Aoyagi H; Yasujima M; Miyazaki S; Kusaka T; Seino M; Otsuka Y; Irokawa N; Chiba S; Sakurai Y; Saito K; Yoshinaga K
    Clin Sci Mol Med Suppl; 1976 Dec; 3():461s-463s. PubMed ID: 799557
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [TREATMENT OF HYPERTENSION IN "THERAPY RESISTANT" CASES].
    SEIFFERT K
    Med Welt; 1964 Jun; 26():1415-6. PubMed ID: 14227538
    [No Abstract]   [Full Text] [Related]  

  • 69. An experiment of prophylactic medication for those with mild hypertension in population.
    Chiba Y; Fukuda Y; Kondo K; Sakuma K; Morioka M; Jitsukawa H; Imai T
    Jpn Circ J; 1965 Aug; 29(8):719-25. PubMed ID: 5318633
    [No Abstract]   [Full Text] [Related]  

  • 70. [EFFECT OF METHYLDOPA AND RESERPINE ON BLOOD PRESSURE AND SALT EXCRETION].
    BIRKENHAEGER WH; GEERLING J; SMORENBERG-SCHOORL ME; OFFERHAUS L; BORST JG
    Ned Tijdschr Geneeskd; 1964 May; 108():968-9. PubMed ID: 14168783
    [No Abstract]   [Full Text] [Related]  

  • 71. Adverse reactions to methyldopa with particular reference to hypotension.
    Lawson DH; Gloss D; Jick H
    Am Heart J; 1978 Nov; 96(5):572-9. PubMed ID: 263390
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacokinetics of hydroflumethiazide during repeated oral administration to healthy subjects.
    Brørs O; Jacobsen S
    Eur J Clin Pharmacol; 1979 May; 15(4):281-6. PubMed ID: 477713
    [No Abstract]   [Full Text] [Related]  

  • 73. Hypertension in general practice. Part I. Examination and investigation of a patient with hypertension.
    Opie LH
    S Afr Med J; 1980 Dec; 58(24):955-60. PubMed ID: 7444697
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Some new diuretics: chlorazinal hydrochloride, hydrochlorothiazide, hydroflumethiazide].
    RAVINA A
    Presse Med (1893); 1959 Nov; 67():2021-2. PubMed ID: 14436570
    [No Abstract]   [Full Text] [Related]  

  • 75. Pharmacokinetics of a single oral dose of hydroflumethiazide in health and in cardiac failure.-.
    Brørs O; Jacobsen S; Arnesen E
    Eur J Clin Pharmacol; 1978 Nov; 14(1):29-37. PubMed ID: 729604
    [No Abstract]   [Full Text] [Related]  

  • 76. Further clinical and biochemical studies with hydroflumethiazide.
    HALER D
    Br J Clin Pract; 1963 Jul; 17():395-6. PubMed ID: 13952076
    [No Abstract]   [Full Text] [Related]  

  • 77. Absorption kinetics of hydroflumethiazide.
    McNamara PJ; Colburn WA; Gibaldi M
    J Clin Pharmacol; 1978 Apr; 18(4):190-3. PubMed ID: 632365
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Clinical research with a new diuretic: hydroflumethiazide potassium salt].
    PISANI E; BOSELLI G
    Minerva Med; 1962 Oct; 53():3159-62. PubMed ID: 13943783
    [No Abstract]   [Full Text] [Related]  

  • 79. [Treatment of obstructive lymphedema with hydroflumethiazide. Etiopathogenetic considerations].
    RIVADENEYRA J; NOGUERA M
    Rev Med Hosp Gen (Mex); 1961; 24():273-8. PubMed ID: 13741928
    [No Abstract]   [Full Text] [Related]  

  • 80. The clinical pharmacological investigation of hydroflumethiazide (saluron).
    FORD RV; NICKELL J
    Antibiotic Med Clin Ther (New York); 1959 Aug; 6():461-9. PubMed ID: 13823912
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.